Efficacy of immunomodulatory therapy with all-trans retinoid acid in adult patients with chronic immune thrombocytopenia

Thrombosis Research

Volumn 140, Issue , 2016, Pages 73-80

  Dai, Lan ^a   Zhang, Ri ^a   Wang, Zhaoyue ^a   He, Yang ^a   Bai, Xia ^a   Zhu, Mingqing ^a   Yu, Ziqiang ^a   Ruan, Chang Geng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

All trans retinoid acid; Chronic immune thrombocytopenia; Immunomodulatory therapy; Regulatory T cells

Indexed keywords

CD4 ANTIGEN; CORTICOSTEROID; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 7 RECEPTOR; PREDNISONE; RETINOIC ACID; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA; IL10 PROTEIN, HUMAN; IMMUNOLOGIC FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; HUMAN; HUMAN CELL; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOMODULATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SPLENECTOMY; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL; TREATMENT RESPONSE; BLOOD; CHRONIC DISEASE; DRUG EFFECTS; HELPER CELL; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

ADULT; CHRONIC DISEASE; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INTERLEUKIN-10; MALE; MIDDLE AGED; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; TRETINOIN;

EID: 84962909797     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2016.02.013     Document Type: Article

References (27)

1. R. McMillan, and C. Durette Long-term outcomes in adults with chronic ITP after splenectomy failure Blood 104 2004 956 960
2. J.E. Portielje, R.G. Westendorp, H.C. Kluin-Nelemans, and A. Brand Morbidity and mortality in adults with idiopathic thrombocytopenic purpura Blood 97 2001 2549 2554
3. J.B. Bussel, D. Provan, T. Shamsi, G. Cheng, B. Psaila, L. Kovaleva, and et al. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial Lancet 373 2009 641 648
4. D.J. Kuter, J.B. Bussel, R.M. Lyons, V. Pullarkat, T.B. Gernsheimer, F.M. Senecal, and et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial Lancet 371 2008 395 403
5. S.K. Vesely, J.J. Perdue, M.A. Rizvi, D.R. Terrell, and J.N. George Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review Ann. Intern. Med. 140 2004 112 120
6. Z.M. Liu, K.P. Wang, J. Ma, and Zheng S. Guo The role of all-trans retinoic acid in the biology of Foxp3 + regulatory T cells Cell. Mol. Immunol. 12 2015 553 557
7. T.R. Breitman, S.J. Collins, and B.R. Keene Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid Blood 57 1981 1000 1004
8. M.E. Huang, Y.C. Ye, S.R. Chen, J.C. Zhao, L.J. Gu, J.R. Cai, and et al. All-trans retinoic acid with or without low dose cytosine arabinoside in acute promyelocytic leukemia. Report of 6 cases Chin. Med. J. 100 1987 949 953
9. M.E. Huang, Y.C. Ye, S.R. Chen, J.R. Chai, J.X. Lu, L. Zhoa, and et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia Blood 72 1988 567 572
10. hi cells Immunity 29 2008 758 770
11. D. Mucida, K. Pino-Lagos, G. Kim, E. Nowak, M.J. Benson, M. Kronenberg, and et al. Retinoic acid can directly promote TGF-beta-mediated Foxp3(+) Treg cell conversion of naive T cells Immunity 30 2009 471 472 (author reply 2-3)
12. C. Neunert, W. Lim, M. Crowther, A. Cohen, L. Solberg Jr., and M.A. Crowther The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia Blood 117 2011 4190 4207
13. M. Osanai, N. Nishikiori, M. Murata, H. Chiba, T. Kojima, and N. Sawada Cellular retinoic acid bioavailability determines epithelial integrity: role of retinoic acid receptor alpha agonists in colitis Mol. Pharmacol. 71 2007 250 258
14. N. Miyagawa, T. Homma, H. Kagechika, K. Shudo, and H. Nagai Effect of synthetic retinoid, TAC-101, on experimental autoimmune disease Pharmacology 67 2003 21 31
15. S.J. Zunino, D.H. Storms, and C.B. Stephensen Diets rich in polyphenols and vitamin A inhibit the development of type I autoimmune diabetes in nonobese diabetic mice J. Nutr. 137 2007 1216 1221
16. M.K. Racke, D. Burnett, S.H. Pak, P.S. Albert, B. Cannella, C.S. Raine, and et al. Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course J. Immunol. 154 1995 450 458
17. R.V. Luckheeram, R. Zhou, A.D. Verma, and B. Xia CD4(+)T cells: differentiation and functions Clin. Dev. Immunol. 2012 2012 925135
18. J. Zhu, and W.E. Paul Heterogeneity and plasticity of T helper cells Cell Res. 20 2010 4 12
19. A. Ward, R.N. Brogden, R.C. Heel, T.M. Speight, and G.S. Avery Etretinate. A review of its pharmacological properties and therapeutic efficacy in psoriasis and other skin disorders Drugs 26 1983 9 43
20. C.E. Brinckerhoff Retinoids and rheumatoid arthritis: modulation of extracellular matrix by controlling expression of collagenase Methods Enzymol. 190 1990 175 188
21. C. Klemann, B.J. Raveney, S. Oki, and T. Yamamura Retinoid signals and Th17-mediated pathology Nihon Rinsho Meneki Gakkai Kaishi = Jpn. J. Clin. Immunol. 32 2009 20 28
22. Y.C. Tsai, H.W. Chang, T.T. Chang, M.S. Lee, Y.T. Chu, and C.H. Hung Effects of all-trans retinoic acid on Th1- and Th2-related chemokines production in monocytes Inflammation 31 2008 428 433
23. C.M. Sun, J.A. Hall, R.B. Blank, N. Bouladoux, M. Oukka, J.R. Mora, and et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid J. Exp. Med. 204 2007 1775 1785
24. X. Zhou, N. Kong, J. Wang, H. Fan, H. Zou, D. Horwitz, and et al. Cutting edge: all-trans retinoic acid sustains the stability and function of natural regulatory T cells in an inflammatory milieu J. Immunol. 185 2010 2675 2679
25. K.M. Elias, A. Laurence, T.S. Davidson, G. Stephens, Y. Kanno, E.M. Shevach, and et al. Retinoic acid inhibits Th17 polarization and enhances Foxp3 expression through a Stat-3/Stat-5 independent signaling pathway Blood 111 2008 1013 1020
26. T.N. Golovina, T. Mikheeva, T.M. Brusko, B.R. Blazar, J.A. Bluestone, and J.L. Riley Retinoic acid and rapamycin differentially affect and synergistically promote the ex vivo expansion of natural human T regulatory cells PLoS One 6 2011 e15868
27. Y.H. Van, W.H. Lee, S. Ortiz, M.H. Lee, H.J. Qin, and C.P. Liu All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells Diabetes 58 2009 146 155